Oseni 25/30
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Oseni 25/30." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2024. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109921/all/Oseni_25_30.
Vallerand AHA, Sanoski CAC, Quiring CC. Oseni 25/30. Davis's Drug Guide. F.A. Davis Company; 2024. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109921/all/Oseni_25_30. Accessed December 1, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2024). Oseni 25/30. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109921/all/Oseni_25_30
Vallerand AHA, Sanoski CAC, Quiring CC. Oseni 25/30 [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2024. [cited 2024 December 01]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109921/all/Oseni_25_30.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oseni 25/30
ID - 109921
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109921/all/Oseni_25_30
PB - F.A. Davis Company
ET - 19
DB - Pediatrics Central
DP - Unbound Medicine
ER -